Document is current
Any future updates will be listed below
-
Authors
Yu, Li-Rong
Cao, Zhijun
Wang, Dong
Daniels, Jaclyn R.
Todorova, Valentina K.
Makhoul, Issam
Klimberg, V. Suzanne
Wei, Jeanne
Bai, Jane P. F.
Lathrop, Julia Tait
Uskievich, Majda Haznadar
Li, Jinong Jenn
Mattes, William
Beger, Richard D.
-
Funding
Funding for this research was provided by:
the U.S. Food and Drug Administration (FDA) Office of Women’s Health, the FDA Chief Scientist Challenge Grant, and the Inter-Center funds from the FDA Center for Drug Evaluation and Research.
- License Information
-
More Information
Article History
Received: 25 March 2026
Accepted: 13 August 2026
First Online: 26 August 2026
Declarations
Ethics approval and consent to participate: This study was approved by the Institutional Review Board (IRB) of the University of Arkansas for Medical Sciences (IRB# 130212) and the U.S. Food and Drug Administration IRB—Research Involving Human Subjects Committee (RIHSC# 14-033 T). Written informed consent was obtained from each patient.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
